Help us make Medscape the best clinical resource possible. Please use this form to submit your questions or comments on how to make this resource center more useful to clinicians.
Purpose The pharmacology, clinical efficacy, safety, dosage and administration, and place in therapy of fidaxomicin for the treatment of Clostridium difficile infection (CDI) are reviewed.
Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI). New therapies like fecal microbiota transplantation (FMT) and monoclonal ...
Considering taking supplements to treat clostridium difficile infection? Below is a list of common natural remedies used to treat or reduce the symptoms of clostridium difficile infection.
diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection is of a different strain. Clostridioides difficile ...
NICE have found that the evidence supporting FMT for recurrent Clostridium difficile infection is sufficient for the procedure to be carried out. However, it is only considered when patients have ...
The therapy re-establishes a healthy microbial community, preventing recurrent Clostridioides difficile infections by outcompeting pathogenic bacteria. The panelist discusses how Rebyota is an FDA ...
These studies have found that gut astrocytes are important regulators of mucosal barrier function and inflammation in inflammatory bowel disease, necrotizing enterocolitis and Clostridium difficile ...
In a nonprofit’s report released this week grading hospitals across the nation on overall performance in keeping patients safe from preventable harm and medical errors, Oroville Hospital received a D.
Research suggests that probiotics may help prevent antibiotic-associated diarrhea and reduce the risk of Clostridioides ...
A current hand gel dispenser in a hospital trust building A world-first in health-protecting hand gel has been tested at Royal Preston Hospital. Health c ...